Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
FreMon Scientific
AddedFeb 16, 2024
UpdatedJun 18, 2026
FreMon Scientific

FreMon Scientific

FreMon Scientific: Specialized manufacturer of efficacious plasma processing medical devices.

HQ
Los Angeles, CA, US
Founded
2013
Overview
Compare
Fundraising
Employees
Website

Founded with a vision to revolutionize medical device manufacturing, FreMon Scientific focuses on creating efficacious plasma processing solutions. Their flagship product, ZipThaw®, is a dry, fast, safe, and portable plasma thawing system designed to enhance the efficiency and safety of plasma thawing in medical settings. The company aims to serve healthcare providers by offering innovative and reliable medical devices that meet stringent regulatory standards including FDA, AABB, CE, ISO, and UL certifications.

FreMon Scientific has garnered attention from notable investors and industry leaders due to its groundbreaking technology and commitment to quality. The ZipThaw® system is featured on ECAT and GSA via GSS, highlighting its acceptance and integration into critical medical supply chains. The company's achievements in regulatory compliance and market penetration underscore its impact on improving plasma processing methodologies, ultimately contributing to better patient outcomes in healthcare facilities worldwide.

FreMon Scientific - Similar Companies

Zenith Technical Innovations logo

Zenith Technical Innovations

Free Flow Medical logo

Free Flow Medical

Plasmology4 logo

Plasmology4

plasmology4.com

FastWave Medical logo

FastWave Medical

Freedom Meditech logo

Freedom Meditech

US Medical Innovations logo

US Medical Innovations

Flotherm logo

Flotherm

flothermtcd.com

Amnio Technology logo

Amnio Technology

BiomedInnovations logo

BiomedInnovations

Mercury Biomed logo

Mercury Biomed

Fast Biomedical logo

Fast Biomedical

Emit logo

Emit

Smisson-Cartledge Biomedical logo

Smisson-Cartledge Biomedical

thermacor1200.com

Velomedix logo

Velomedix

Jointechlabs logo

Jointechlabs

jointechlabs.com

FreMon Scientific - Quick Facts

Who are FreMon Scientific's competitors?

Companies similar to FreMon Scientific include Zenith Technical Innovations, Free Flow Medical, Plasmology4 and FastWave Medical.

When was FreMon Scientific founded?

FreMon Scientific was founded in 2013.

Where is FreMon Scientific's headquarters located?

FreMon Scientific's headquarters is located in Los Angeles, CA, US.

When was FreMon Scientific's last funding round?

FreMon Scientific's most recent funding round was for $2M (USD) in March 2018.

How much has FreMon Scientific raised to-date?

As of Mar 21, 2018, FreMon Scientific has raised a total of $2M (USD).

How many employees does FreMon Scientific have?

FreMon Scientific has 8 employees as of Feb 5, 2024.

FreMon Scientific - Classification

Industry
  • Hardware
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Transactional
Customer
  • Enterprise
  • Government
Main Product
  • Medical Devices
Tags
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified